Hepatitis C Treatment Market by Drug class, Route of administration and Distribution channel. Market Leaders are GlaxoSmithKline, Bristol-Myers Squibb, F. Hoffmann- La Roche Ltd, Merck, Johnson & Johnson, Gilead Sciences, AbbVie, Vertex Pharmaceuticals an

Hepatitis C is an infectious disease caused by Hepatitis C virus (HCV) and affects primarily the liver. Hepatitis C is commonly caused by blood to blood contacts such as intravenous drug use, unsterilized equipment, blood transfusions, and sexual intercourse.

The global Hepatitis C treatment market is boosting due to following factors-
• Increased cases and awareness about the HCV infection
• Government initiatives and various policies helping the cause
• Increasing fund in R & D activities
• New and innovative drug production

Though, absence of antibiotics, expensive medications, and dearth of hepatitis C infection awareness in underdeveloped countries can hamper the market growth of hepatitis C treatment globally.

Market summary:

According to the World Health Organization (WHO), there are 80 Mn people worldwide suffering from chronic hepatitis C virus (HCV), in that approximately 700,000 will die each year as a result of the HCV infection. Collaborations, acquisitions and mergers, new product launches, increase in R & D activities, and sanctions for new products from various drug regulatory bodies such as U.S. FDA are some key tactics followed by various businesses to boost their market growth in global Hepatitis C treatment market.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-treatment-market/

Regional analysis
North America dominates the global hepatitis C infection market and is closely followed by Europe. Factors such as increased HCV infections, rise in awareness, rise in technological advancements and acceptance of newer products and more R&D activities are help grow the North America market.

According to European Center for Disease Prevention and Control approx. 5.9 million people are suffering from HCV infection. Other factors leading the European market growth for hepatitis C treatment market are increase in older population pool, lifestyle transformation, and unprotected sexual intercourse.

Avail sample report at https://bit.ly/2RUfDt3

Asia-Pacific hepatitis C treatment market is growing owing to increasing cases of HCV infection, rise in the population and increase in the healthcare set-up.
The Middle East & Africa region has highest cases of HCV infection mainly in Egypt that is approximately 8434 prevalent cases per 100,000 people.

Notable market development:
Mavyret (Glecaprevir/Pibrentasvir) by AbbVie received FDA approval in 2017 for treatment of chronic hepatitis C virus (HCV) infection in all major genotypes (GT1-6)

Some of the key players in the global Hepatitis C treatment market are
• GlaxoSmithKline, plc. (U.K.)
• Bristol-Myers Squibb (U.S)
• F. Hoffmann- La Roche Ltd. (Switzerland)
• Merck & Co, Inc. (U.S)
• Johnson & Johnson Services, Inc. (U.S.)
• Gilead Sciences (U.S.)
• AbbVie Inc. (U.S.)
• Vertex Pharmaceuticals Inc. (U.S.)
• Kadmon Holdings, Inc. (U.S.)

The global Hepatitis C treatment market is categorized on the basis of drug class, route of administration, end-users and geographical regions.

By drug class
• Polymerase Inhibitors
• NS5A Inhibitors
• Interferons
• HCV protease inhibitors
• Combination Therapy

By route of administration
• Oral
• Parenteral

By end-users
• Retail Pharmacies
• Hospital Pharmacies
• Others

By geographical regions
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.